Spitz naevi may express components of the plasminogen activation system

Journal of Pathology

Volumn 198, Issue 1, 2002, Pages 92-99

  Ferrier, Cilia M ^a   Van Geloof, Winny L ^a   Straatman, Huub ^a   Van De Molengraft, Fred J J M ^b   Van Muijen, Goos N P ^a   Ruiter, Dirk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Activation; Immunohistory; Melanoma; Plasminogen; Serine protease system; Splitz nevus

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPLASTIC NEVUS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HAND; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; METASTASIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

DIAGNOSIS, DIFFERENTIAL; DYSPLASTIC NEVUS SYNDROME; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; NEVUS, EPITHELIOID AND SPINDLE CELL; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; RECEPTORS, CELL SURFACE; SERINE PROTEINASE INHIBITORS; SKIN NEOPLASMS; STROMAL CELLS; TISSUE PLASMINOGEN ACTIVATOR; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036724661     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1167     Document Type: Article

References (35)

1. Spitz naevi and malignant melanomas of childhood and adolescence
2. The histology and differential diagnosis of Spitz nevus
3. Cutaneous melanoma and atypical Spitz tumors in childhood
4. Spitz naevi misdiagnosed histologically as melanoma: Prevalence and clinical profile
5. Quality assessment by expert opinion in melanoma pathology: Experience of the pathology panel of the Dutch melanoma working party
6. Spitz nevus versus spitzoid malignant melanoma: An evaluation of the current distinguishing histopathologic criteria
7. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)
8. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression
9. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
10. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue
11. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues
12. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
13. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues
14. Proteolytic enzymes and plasminogen activator in melanoma
15. Plasminogen activation in melanocytic neoplasia
16. The plasminogen activation system in melanoma cell lines and in melanocytic lesions
17. Proteases in cutaneous melanoma
18. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression
19. Validity of the histopathological criteria used for diagnosing dysplastic naevi: An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group
20. Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques
21. A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols
22. Urokinase receptor in breast cancer tissue extracts: Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies
23. Interactions of melanocytes and melanoma cells with the microenvironment
24. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors
25. The migratory pathway of neural crest cells into the skin of mouse embryos
26. Origin of pigment cells from the neural crest in the mouse embryo
27. CD40 is a prognostic marker in primary cutaneous malignant melanoma
28. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution
29. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas
30. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: An adjunct for recognition of the vertical growth phase in malignant melanomas?
31. Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions
32. Immunohistochemical study of p53 protein expression in Spitz nevus as compared with other melanocytic lesions
33. Measurement of the maturation parameter by using computer-assisted interactive image analysis may be helpful in the differential diagnosis between compound Spitz nevus and malignant melanoma
34. DNA in situ hybridization as a diagnostic tool in the discrimination of melanoma and Spitz naevus
35. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid